港股異動丨港交所(0388.HK)漲4.51%再創新高 上交所科創板A股2月1日起納滬股通
格隆匯1月25日丨港交所(0388.HK)漲4.51%,報533.5港元再創歷史新高,總市值6764億港元。上交所公佈《上海證券交易所滬港通業務實施辦法(2021年修訂)》,落實科創板A股納入港股通的準則,在上證180指數、上證380指數、A+H股上市公司的科創板A股,將納入滬股通北向交易範圍。合資格科創板A股將於2021年2月1日(星期一)起納入滬深港通股票範圍,不過科創板成為北向交易首個設有準入門檻的投資標的,只限據聯交所規則界定的機構專業投資者參與。港交所表示,A股在深交所上市的A+H股公司,其對應的H股也將於2月1日起正式可透過滬港通下的港股通買賣,並指未來滬深港三所會繼續密切合作,持續改良互聯互通機制。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.